Original Research Article
Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts
Article first published online: 28 JAN 2013
Copyright © 2012 Wiley Periodicals, Inc.
Journal of Cellular Physiology
Volume 228, Issue 5, pages 983–990, May 2013
How to Cite
Tu, H.-J., Lin, T.-H., Chiu, Y.-C., Tang, C.-H., Yang, R.-S. and Fu, W.-M. (2013), Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts. J. Cell. Physiol., 228: 983–990. doi: 10.1002/jcp.24244
- Issue published online: 28 JAN 2013
- Article first published online: 28 JAN 2013
- Accepted manuscript online: 5 OCT 2012 07:49AM EST
- Manuscript Accepted: 26 SEP 2012
- Manuscript Received: 29 MAY 2012
- National Science Council of Taiwan. Grant Number: NSC 99-2628-B-002-040-MY3
Additional Supporting Information may be found in the online version of this article.
|jcp_24244_sm_SupplFig1.tif||7301K||Supplementary Figure 1. OSM increases PLGF expression in human synovial fibroblasts derived osteoarthritis patients (OASFs). (A) OSM receptors were examined by specific primers for RT-PCR in human synovial fibroblasts. (B) Synovial fibroblasts derived from 3 OA patients were treated with various concentrations of OSM (1∼30 ng/ml) for 24 hours. Note that OSM concentration-dependently enhanced PLGF production.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.